• Our Solution
  • About
  • Team
UltraSight
  • FDA Grants Clearance for UltraSight’s AI-Powered Cardiac Ultrasound Technology

    UltraSight

    July 27, 2023
    Uncategorized

    New AI guidance software will allow more medical professionals to conduct cardiac ultrasound in multiple care settings expanding patient access to cardiac imaging TEL AVIV, Israel, July 27, 2023 — Today, UltraSight, a digital health pioneer transforming cardiac imaging through the power of artificial intelligence, announced that it has been granted FDA clearance for its AI-powered ultrasound guidance […]

  • UltraSight and EchoNous Partner to Enable More Accessible Cardiac Ultrasound for Patients  

    UltraSight

    June 23, 2023
    Uncategorized

    New partnership to bring the benefits of cardiac imaging to new healthcare settings NATIONAL HARBOR, MD., June 23, 2023 – Today, UltraSight, a digital health pioneer transforming cardiac imaging through the power of artificial intelligence, announced a partnership with point-of-care ultrasound innovator EchoNous, to enable more healthcare professionals to perform cardiac ultrasound and help increase patient access […]

  • UltraSight Granted Patent for Real-Time Guidance Ultrasound Technology

    UltraSight

    February 28, 2023
    Uncategorized

    OnSight Wins TCT connect 2020 Shark Tank Innovation Competition

  • New Landmark Study Indicates UltraSight Enables Novice Ultrasound Users to Capture High Quality Cardiac Images

    UltraSight

    November 28, 2022
    Uncategorized

    Findings confirm diagnostic echocardiographic exams can be performed by medical professionals without sonography experience by using UltraSight TEL AVIV, Israel, Nov. 28, 2022 — UltraSight, an Israeli-based digital health pioneer transforming cardiac imaging through the power of artificial intelligence, today announced new findings from a landmark pivotal study. According to the results, UltraSight’s AI guidance and quality […]

  • UltraSight Receives CE Mark for Novel Cardiac AI Technology

    UltraSight

    August 25, 2022
    Uncategorized

    UltraSight Selected to Conduct a Study Onboard the International Space Station

  • New Study Reveals UltraSight & Sheba Medical Center Enable Novice Ultrasound Users to Obtain Accurate, Diagnostic Quality Cardiac Images

    UltraSight

    May 26, 2022
    Uncategorized

    Images acquired with AI guidance software deemed usable in 100 percent of cardiac patients TEL AVIV, Israel, May 26, 2022 — At the 69th Annual Conference of the Israel Heart Society, UltraSight, an Israeli-based digital health pioneer transforming cardiac imaging through the power of artificial intelligence, and Sheba Medical Center Israel revealed new research findings from a blinded pilot study that […]

  • UltraSight Announces Appointment of Dr. Ruth Atherton, JD to Board of Directors

    UltraSight

    May 3, 2022
    Uncategorized

    Expansion of board signals digital health company’s growth and increased focus on creating access to cardiac ultrasound TEL AVIV, Israel, May 3, 2022 — UltraSight, an Israeli-based digital health pioneer transforming cardiac imaging through the power of artificial intelligence, is proud to announce that Ruth Atherton, PhD, JD, has joined its board of directors. Dr. Atherton has a […]

  • UltraSight Collaboration with GE Healthcare will bring Wireless Cardiac Point of Care Ultrasound to Space

    UltraSight

    September 20, 2021
    Uncategorized

    Technology developed through partnership to monitor astronaut’s heart during ‘Rakia’ space mission CHICAGO and TEL AVIV, ISRAEL, Sept. 30, 2021 — UltraSight, a digital health pioneer transforming cardiac imaging through the power of AI, announced a new collaboration with GE Healthcare to conduct a cardiac study aboard the Axiom ‘Rakia’ space mission, and the successful completion of Preliminary Design Review (PDR) […]

  • UltraSight Raises $13 million to Bring AI Guidance for Cardiac Ultrasound to Patient Point of Care

    UltraSight

    May 11, 2021
    Uncategorized

    Digital Health company transforming ultrasound industry TEL AVIV, Israel, May 11, 2021 — UltraSight (formerly OnSight Medical), a Digital Health pioneer for cardiac imaging and beyond, announced today that it has closed a $13 million Series B funding round. The investment will be used to advance U.S. clinical programs for its real time, AI guidance in a variety of care […]

Pinhas Sapir St 8, Ness Ziona,
Israel 7403631

info@ultrasight.com

Contact Us

Contact Us Global

Section

Section

UltraSight is committed to protecting and respecting your privacy, and we’ll only use and process your personal information to respond to your message and as described in our Privacy Policy.

Privacy policy *

Occasionally, we would like to contact you by email about our products and services, as well as other content that may be of interest to you. You may unsubscribe from such emails via the link provided in the emails. If you consent to receive such emails from us, please tick below:

Marketing contact

  • LinkedIn
  • Twitter

Terms of Use

Privacy Policy

Regulatory Approvals and Labeling

User Manual

Design: Anzelevich Code: E&R © All copyright reserved to UltraSight

UltraSight is thrilled to announce that we have received FDA clearance for UltraSight AI Guidance

Read the full press release